HIV.IND.9 Logic - XML Representation - WHO SMART Guidelines

WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
: HIV.IND.9 Logic - XML Representation

Draft as of 2025-01-02
Raw xml | Download

<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND9Logic"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile
             value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile
             value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile
             value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
<div>
    <table class="grid dict">
        
        
        <tr>
            <th scope="row"><b>Title: </b></th>
            <td style="padding-left: 4px;">HIV.IND.9 Logic</td>
        </tr>
        

        
        
        <tr>
            <th scope="row"><b>Id: </b></th>
            <td style="padding-left: 4px;">HIVIND9Logic</td>
        </tr>
        

        
        
        <tr>
            <th scope="row"><b>Version: </b></th>
            <td style="padding-left: 4px;">0.3.0</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Url: </b></th>
            <td style="padding-left: 4px;"><a href="Library-HIVIND9Logic.html">HIV.IND.9 Logic</a></td>
        </tr>
        

        

        

        
        <tr>
            <th scope="row"><b>Status: </b></th>
            <td style="padding-left: 4px;">draft</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Experimental: </b></th>
            <td style="padding-left: 4px;">true</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Type: </b></th>
            <td style="padding-left: 4px;">
                
                    
                        
                        <p style="margin-bottom: 5px;">
                            <b>system: </b> <span><a href="http://terminology.hl7.org/6.0.2/CodeSystem-library-type.html">http://terminology.hl7.org/CodeSystem/library-type</a></span>
                        </p>
                        
                        
                        <p style="margin-bottom: 5px;">
                            <b>code: </b> <span>logic-library</span>
                        </p>
                        
                        
                    
                
                
            </td>
        </tr>
        

        

        
        <tr>
            <th scope="row"><b>Date: </b></th>
            <td style="padding-left: 4px;">2025-01-02 00:27:00+0000</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Publisher: </b></th>
            <td style="padding-left: 4px;">WHO</td>
        </tr>
        

        
        <tr>
            <th scope="row"><b>Description: </b></th>
            <td style="padding-left: 4px;"><div><p>% of people who inject drugs accessing a needle-syringe programme (NSP) at least once per month during the reporting period</p>
</div></td>
        </tr>
        

        

        

        

        

        

        

        

        

        

        

        

        

        

        
        
        <tr>
          <td colspan="2">
            <table>
              <tr><th><a id="cql-content"><b>Content: </b></a> text/cql</th></tr>
              <tr><td><pre><code class="language-cql">/**
 * Library: HIV.IND.9 Logic
 * Ref No: PRV.9
 * Short Name: Regular NSP access
 *
 * Definition: % of people who inject drugs accessing a needle-syringe programme (NSP) at least once per month during the reporting period
 *
 * Numerator: Total number of people receiving needles-syringes at least once per month during the reporting period, either: | a) number of people accessing an NSP at least once in each 30-day period of the reporting period | b) number of people accessing an NSP at least once per month on average during the reporting period
 * Numerator Calculation: COUNT of clients with &quot;Date injecting equipment provided&quot; within each 30 day period of reporting period
 * Numerator Exclusions: 
 *
 * Denominator: a) Programme/service provider level: number of people who inject drugs accessing service | b) Population level: population-size estimate of people who inject drugs in relevant geographic area
 * Denominator Calculation: Programme/service level:  | COUNT of clients with &quot;Key population member type&quot;='People who inject drugs' |  | Population level: | *Estimated number of people who inject drugs
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other*) 
 *  • Age (&lt;25, 25+ years) 
 *  • Provider type (key population-led or community-led organization, public sector provider, other entities such as private for-profit and not-for-profit organizations, including faith-based, international, nongovernmental) 
 *  • Setting: facility-based service (including hospitals, health clinics, general practice offices, etc.) or community-based service (including drop-in centres, community service delivery points, mobile clinics or vans, outreach teams, community support groups, etc.) 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age (&lt;25, 25+ years)
 *
 * Numerator and Denominator Elements:
 * Date injecting equipment provided 
 *  Key population member type
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE50: Key population member type* | The type of key population that the client is included in
 * HIV.B.DE51: Sex worker | Client is a sex worker
 * HIV.B.DE52: Men who have sex with men | Client is a man who has sex with men
 * HIV.B.DE53: Trans and gender-diverse people | Client identifies as trans and gender-diverse
 * HIV.B.DE54: People who inject drugs | Client is a person who injects drugs
 * HIV.B.DE55: People living in prisons and other closed settings | Client lives in a prison or another closed setting
 * HIV.E.DE114: Key population member type* | The type of key population that the infant's mother is included in
 * HIV.E.DE115: Sex worker | Infant's mother is a sex worker
 * HIV.E.DE116: People who inject drugs | Infant's mother is a person who injects drugs
 * HIV.E.DE117: Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse
 * HIV.E.DE118: People living in prisons and other closed setting | Infant's mother is in a prison or closed setting
 * HIV.PRV.DE15: Date injecting equipment provided | Date client was provided with injecting equipment
 *
 * Additional Context
 * - what it measures: This indicator measures the frequency that people who inject drugs access a NSP.
 * - rationale: Frequent and regular access to an NSP by people who inject drugs is encouraged to ensure availability of sterile injecting equipment.
 * - method: Individual-level data obtained from programmatic records.
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

 /* 
  * Profiles:
  * - 

library HIVIND9Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'

include WHOCommon called WCom

// Indicator Definition
parameter &quot;Measurement Period&quot; Interval&lt;Date&gt; default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define &quot;Initial Population&quot;:
  true

/**
 * Numerator
 * 
 * Definition: Total number of people receiving needles-syringes at least once per month during the reporting period, either: | a) number of people accessing an NSP at least once in each 30-day period of the reporting period | b) number of people accessing an NSP at least once per month on average during the reporting period
 * Calculation: COUNT of clients with &quot;Date injecting equipment provided&quot; within each 30 day period of reporting period
 */

define &quot;Numerator&quot;:
  true

/**
 * Denominator
 *
 * Definition: a) Programme/service provider level: number of people who inject drugs accessing service | b) Population level: population-size estimate of people who inject drugs in relevant geographic area
 * Calculation: Programme/service level:  | COUNT of clients with &quot;Key population member type&quot;='People who inject drugs' |  | Population level: | *Estimated number of people who inject drugs
 */

define &quot;Denominator&quot;:
  true
    

/* end Populations */

</code></pre></td></tr>
            </table>
          </td>
        </tr>
        
        
        
        
        
        <tr>
          <td colspan="2">
            <table>
              <tr><th><b>Content: </b> application/elm+xml</th></tr>
              <tr><td><pre><code/></pre></td></tr>
            </table>
          </td>
        </tr>
        
        
    </table>
</div>
</div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/hiv/Library/HIVIND9Logic"/>
  <version value="0.3.0"/>
  <name value="HIVIND9Logic"/>
  <title value="HIV.IND.9 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2025-01-02T00:27:00+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description
               value="% of people who inject drugs accessing a needle-syringe programme (NSP) at least once per month during the reporting period"/>
  <content>
    <contentType value="text/cql"/>
    <data
          value="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"/>
  </content>
  <content>
    <contentType value="application/elm+xml"/>
  </content>
</Library>
IG © 2023+ WHO. Package smart.who.int.hiv#0.3.0 based on FHIR 4.0.1. Generated 2025-01-02
Links: Table of Contents | QA Report | Version History | License